 |
|
|
| |
Effects of Inarigivir (SB9200) Therapy on Immune Responses in Patients with Chronic Hepatitis B (CHB)
|
| |
| |
pdf of slide presentation attached so you can read small details of data in slides below
Download the PDF here
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Renae Walsh1, Rachel Hammond1, Kathy Jackson1, Ros
Edwards1, Chelsea Macfarlane2, Radhakrishnan P. Iyer2,
Man-Fung Yuen3, Henry LY Chan4, Nezam H. Afdhal2,
Stephen Locarnini1
1 Victorian Infectious Diseases Reference Laboratory,
Melbourne, Australia
2 Spring Bank Pharmaceuticals, Hopkinton, MA, United States
3 University of Hong Kong, Hong Kong, Hong Kong
4 Chinese University of Hong Kong, Hong Kong, Hong Kong
|
| |
|
|
|
|
|
